Skip to main content
. 2011 Oct 12;23(5):1335–1340. doi: 10.1093/annonc/mdr442

Figure 1.

Figure 1.

Computed tomography of patient #2 shows that imatinib at 800 mg/day may induce a partial response in gastrointestinal stromal tumor (GIST) and desmoid tumor (DT). Arrows indicate tumor localization.